Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

FIRAZYR – Treatment for Hereditary Angioedema

Drug Name (Brand / Generic)

FIRAZYR / Icatibant

Company / Licensee

Jerini / Shire

Therapy Class

Bradykinin B2 receptor antagonist

Drug Indication

Hereditary angioedema

Market Sector

Haematology

Development Status

Approved in the US, EU, Australia, Brazil, Israel and Denmark
Expand
Close
Close
Close

Go Top